Virología Vacuna de Rotavirus: Experiencia en Venezuela
Referencias
1.- Bloom DE, Williamson JG. Demographic transitions and
economic miracles in emerging Asia. The World Bank Economic Review. 1998;
12:419-455.
2.- Parashar UD, Hummelan EG, Bresee JS, Miller MA, Glass RI.
Global illness and deaths caused by rotavirus disease in children. Emerg Infect
Dis. 2003; 9: 565-572.
3.- Pérez-Schael I. The impact of rotavirus disease
in Venezuela. J Infect Dis 1996; 174:S19-21.
4.- Salinas B, González G, González R, Escalona M, Materán
M, Pérez Schael I. Epidemiologic and clinical characteristics
of rotavirus disease during five years of surveillance in Venezuela. Pediatr
Infect Dis J 2004; S161-167.
5.- Pérez-Schael I, Salinas B, Escalona M, González
G, Barrios I, Materán M. Rotavirus mortality in Venezuelan
infants. III World Congress of Pediatric Infectious Disease- WSPID Chile,
2002; pp: 87
6.- Hoshino Y, Kapikian AZ. Rotavirus serotypes: clasification
and importance in epidemiology, immunity, and vaccine development. J Health
Popul Nutr 2000; 18:5-14.
7.- White L, García D, Boher Y, Blanco M, Pérez M, Romer
H, et al. Temporal distribution of human rotavirus serotypes 1, 2,
3, and 4 in venezuelan children with gastroenteritis during 1979-1989. J Med
Virol 1991; 34:79-84.
8.- Gentsch JR, Woods PA, Ramachandran M, Das BK, Leite JP, Alfieri
A, et al. Review of G and P typing results from a global collection
of rotavirus strains: implications for vaccine development. J Infect Dis 1996;
174:S30-36.
9.- Pérez-Schael I, González R, Fernández R,
Alfonzo E, Inaty D, Boher Y, et al. Epidemiological features of rotavirus
infection in Caracas, Venezuela: Implications for rotavirus immunization programs.
J Med Virol 1999; 59:520-526.
10.- Santos G y Hoshino T. Global distribution of rotavirus
serotypes/genotypes and its implication for the development and implementation
o fan effective rotavirus vaccine. Rev. Med Virol. 2005; 15:29-56.
11.- Pérez-Schael I, González R, Salinas B, Villaroel
M, Tomat M y Yarzábal JP. Rotavirus: control y prevención.
Vitae 2003 (15); http://caibco.ucv.ve
12.- Bresee JS, Glass RI, Ivanoff B, Gentsch JR. Current
status and future priorities for rotavirus vaccine development, evaluation
and implementation in developing countries. Vaccine 1999; 17:2207-2222.
13.- Kapikian AZ, Hoshino Y, Chanock RM, Pérez-Schael I.
Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine
aimed at preventing severe rotavirus diarrhea in infants and young children.
J Infect Dis 1996; 174:S65-72.
14.- De Vos B, Vesikari T, Linhares AC, Salinas B, Pérez Schael
I, Ruiz-Palacios MG . A rotavirus vaccine for prophylaxis of infants
against rotavirus gastroenteritis. Pediatr Infect Dis J 2004; S179-182.
15.- Pérez ME, Glass RI, Alvarez G, Pericchi LR, González
R, Kapikian AZ, Pérez Schael I. Rhesus rotavirus-based quadrivalent
vaccine is efficacious despite age, socioeconomic conditions and seasonality
in Venezuela. Vaccine 2001; 19:976-981.
16.- Hoshino Y, Wagner M, Yan X, Pérez-Schael I, Kapikian AZ.
Horizontal transmission of rhesus monkey rotavirus-based quadrivalent vaccine
during a phse 3 clinical trial in Caracas, Venezuela. JID 2003; 187:791-800.
17.- CDC. Centers for Disease Control and Prevention. Rotavirus
vaccine for the prevention of rotavirus gastroenteritis among children. Recommendatios
of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly
Rep 1999;48 (RR-2):1-20
18.- Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro
CA, et al. Intussusception among infants given oral rotavirus vaccine.
New Engl J Med 2001; 344: 564-572.
19.- Simonsen L. Reappraisal of association between rotavirus
vaccine and intussusception. Presentado en Sixth international rotavirus symposium.
2004. pp.45. México City, México.
20.- Berhrman RE, Kliegman RM, Arvin AM, Nelson WE. Tratado
de pediatría Nelson. 15th ed. 1997. Madrid, España: McGraw Hill
Interamericana.
21.- Pérez-Schael I, Escalona M, Salinas B, Materán
M, Pérez ME, González G. Intussusception-associated
hospitalization among Venezuelan infants during 1998 through 2001:anticipating
rotavirus vaccines. Pediatric Infect Dis J 2003; 22:234-239.
22.- WHO. Report of the meeting on future directions for
rotavirus vaccine research in developing countries. Geneva, Switzerland. Febrero
9-11, 2000.
23.- Bernstein DI, Smith VE, Sherwood JR, Schiff GM, Sander DS, DeFeudis
D, et al. Safety and immunogenicity of live, attenuated human rotavirus
vaccine 89-12. Vaccine 1998; 16:381-387.
24.- Bernstein DI, Sack DA, Rothstein E, Reisinger K, Smith VE, O’Sullivan
D, et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12
in infants: a randomised placebo-controlled trial. Lancet 1999; 354:287-290.
25.- Bishop RF, Barnes GL, Cipriani E, and Lund JS. 1983.
Clinical immunity after neonatal rotavirus infection. A prospective longitudinal
study in young children. N Engl J Med 309:72-76.
26.- Velázquez FR, Matson DO, Calva JJ, Guerrero ML, Morrow
AL, Carter-Campbell S, et al. 1996. Rotavirus infection in infants
as protection against subsequent infections. N Engl J Med 335:1022-1028.
27.- Vesikari T, Karvonen A, Puustinen L, Zeng S-Q, Szakal ED, Delem
A, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine
in Finnish infants. PJID 2004; 23:937-943.
28.- Pérez-Schael I, García D, González M, González
R, Daoud N, Pérez M, et al. Prospective study of diarrheal
diseases in venezuelan children to evaluate the efficacy of rhesus rotavirus
vaccine. J Med Virol 1990; 30:219-229.
29.- Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone
V, Rojas AM, González R,et al. Efficacy of the rhesus rotavirus-based
quadrivalent vaccine in infants and young children in Venezuela. N Engl J
Med 1997; 337:1181-1187.
30.- Salinas B, Tomat M, Yarzábal JP, Peiró M, González
G, Fierro A, et al. Eficacia de la vacuna de rotavirus (Rotarix)
en niños venezolanos. Presentado en Asovac, 2004, Valencia, Edo. Carabobo,
Venezuela.
31.- O´Ryan M, Lanata C, Abate H, Pérez Schael I, Rivera
M, Ortega E, et al. A novel rotavirus vaccine RIX4414 is not associated
with intussusception. Presentado en ICAAC, 2004, Washington, USA.
NOTA:Toda la información que se brinda en este artículo es de carácter investigativo y con fines académicos y de actualización para estudiantes y profesionales de la salud. En ningún caso es de carácter general ni sustituye el asesoramiento de un médico. Ante cualquier duda que pueda tener sobre su estado de salud, consulte con su médico o especialista.
Instituto de Medicina Tropical - Facultad de Medicina - Universidad Central de Venezuela.
Elaborado por el Centro de Análisis de Imágenes Biomédicas Computarizadas CAIBCO, caibco@ucv.ve
Este portal ha sido desarrollado gracias al apoyo del Fonacit
